Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
tolvaptan (samsca) (1 trial)
Diabetes Insipidus (Phase 3)
Heart Failure (Phase 3)
Trials (1 total)
Trial APIs (1 total)